Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05850195
Other study ID # NIV failure in acute RF
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 1, 2023
Est. completion date June 1, 2025

Study information

Verified date March 2023
Source Assiut University
Contact Asmaa Razek
Phone 01061855512
Email drasmaarazek85@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will use different indices for prediction of NIV failure in ARF patients Evaluation of HACOR score and ROX index for early prediction of NIV failure in patients with ARF. Study value of diaphragmatic dysfunction assessed by ultrasound as tool for prediction of success of NIV in ARF patients. Compare clinical significance of these scoring systems between hypoxemic and hypercapnic RF


Description:

Noninvasive ventilation (NIV) is a useful and safe method to improve gas exchange in patients with acute respiratory failure (ARF) of different etiologies. NIV reduces the work of breathing, improves arterial oxygenation and alveolar ventilation. It is associated with improved survival in the acute care setting (Cabrini L 2015) when compared to conventional oxygen therapy. As NIV offers several major advantages over invasive ventilation (e.g., preserving the ability to swallow, cough, and communicate verbally), it is widely used to avoid intubation. Although NIV nowadays is frequently used, its failure rate remains high (25-59%), indicating that not all patients benefit from this treatment. There is an association between the unsuccessful NIV and the poor outcome has been suggested. Among patients who experience NIV failure, either premature or delayed NIV discontinuation further increases mortality. Thus, identifying the predictors of NIV failure is crucial because of the strong link between failure and poor outcomes. So, researchers woke to make scoring systems that may predict NIV failure, as HACOR and ROX indices. Recently, ultrasonography (US) of the diaphragm as a bedside method is used for evaluation of diaphragmatic function and predicting failure of NIV in acutely ill patients. Up till now there is limited research to support significance of different indices for prediction of NIV failure and need for invasive mechanical ventilation (IMV).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 70
Est. completion date June 1, 2025
Est. primary completion date December 1, 2024
Accepts healthy volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: 1. Patients with acute hypoxic respiratory failure who need Noninvasive ventilation. 2. Patients with acute hypercapnic respiratory failure who need Noninvasive ventilation. Exclusion Criteria: 1. Age < 18 years old. 2. Patients with unconsciousness, severe hemodynamic instability, unable to fit mask (Recent facial surgery, trauma, or deformity), inability to protect the airway or clear respiratory secretions or any other contraindication of NIV. 3. neuromuscular disease or chest wall deformities. 4. Pregnancy. 5. NIV intolerance. 6. severe obesity with Body Mass Index (BMI)=35 kg/m2

Study Design


Related Conditions & MeSH terms


Intervention

Other:
non invasive ventilation
compare indices and diaphragmatic ultrasonography for prediction of NIV failure in acute RF patients

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (3)

Demoule A, Girou E, Richard JC, Taille S, Brochard L. Benefits and risks of success or failure of noninvasive ventilation. Intensive Care Med. 2006 Nov;32(11):1756-65. doi: 10.1007/s00134-006-0324-1. Epub 2006 Sep 21. — View Citation

Matamis D, Soilemezi E, Tsagourias M, Akoumianaki E, Dimassi S, Boroli F, Richard JC, Brochard L. Sonographic evaluation of the diaphragm in critically ill patients. Technique and clinical applications. Intensive Care Med. 2013 May;39(5):801-10. doi: 10.1007/s00134-013-2823-1. Epub 2013 Jan 24. — View Citation

Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernandez G, Garcia-de-Acilu M, Frat JP, Masclans JR, Ricard JD. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy. Am J Respir Crit Care Med. 2019 Jun 1;199(11):1368-1376. doi: 10.1164/rccm.201803-0589OC. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary measure value of HACOR score for prediction of failure of NIV in ARF patients. HACOR score (Heart rate, Acidosis, Consciousness, Oxygenation, Respiratory rate) It will be analyzed as continuous value and dichotomized as = or > 5 Baseline (before starting NIV treatment)
Primary measure value of HACOR score for prediction of failure of NIV in ARF patients. HACOR score (Heart rate, Acidosis, Consciousness, Oxygenation, Respiratory rate) It will be analyzed as continuous value and dichotomized as = or > 5 at 1 hour of NIV treatment
Primary measure value of HACOR score for prediction of failure of NIV in ARF patients. HACOR score (Heart rate, Acidosis, Consciousness, Oxygenation, Respiratory rate) It will be analyzed as continuous value and dichotomized as = or > 5 at 6 hours of NIV treatment
Primary measure value of HACOR score for prediction of failure of NIV in ARF patients. HACOR score (Heart rate, Acidosis, Consciousness, Oxygenation, Respiratory rate) It will be analyzed as continuous value and dichotomized as = or > 5 at 12 hours of NIV treatment
Primary measure value of HACOR score for prediction of failure of NIV in ARF patients. HACOR score (Heart rate, Acidosis, Consciousness, Oxygenation, Respiratory rate) It will be analyzed as continuous value and dichotomized as = or > 5 at 24 hours of NIV treatment
Primary measure value of HACOR score for prediction of failure of NIV in ARF patients. HACOR score (Heart rate, Acidosis, Consciousness, Oxygenation, Respiratory rate) It will be analyzed as continuous value and dichotomized as = or > 5 at 48 hours of NIV treatment
Primary measure value of ROX index for prediction of failure of NIV in ARF patients. ROX index is the ratio of oxygen saturation as measured by pulse oximetry (SpO2)/ fraction of inspired oxygen (FIO2) to respiratory rate (RR). It will be analyzed as continuous value and dichotomized as < or = 4.88 Baseline (before starting NIV treatment)
Primary measure value of ROX index for prediction of failure of NIV in ARF patients. ROX index is the ratio of oxygen saturation as measured by pulse oximetry (SpO2)/ fraction of inspired oxygen (FIO2) to respiratory rate (RR). It will be analyzed as continuous value and dichotomized as < or = 4.88 at first hour of NIV treatment
Primary measure value of ROX index for prediction of failure of NIV in ARF patients. ROX index is the ratio of oxygen saturation as measured by pulse oximetry (SpO2)/ fraction of inspired oxygen (FIO2) to respiratory rate (RR). It will be analyzed as continuous value and dichotomized as < or = 4.88 at 6 hours of NIV treatment
Primary measure value of ROX index for prediction of failure of NIV in ARF patients. ROX index is the ratio of oxygen saturation as measured by pulse oximetry (SpO2)/ fraction of inspired oxygen (FIO2) to respiratory rate (RR). It will be analyzed as continuous value and dichotomized as < or = 4.88 at 12 hours of NIV treatment
Primary measure value of ROX index for prediction of failure of NIV in ARF patients. ROX index is the ratio of oxygen saturation as measured by pulse oximetry (SpO2)/ fraction of inspired oxygen (FIO2) to respiratory rate (RR). It will be analyzed as continuous value and dichotomized as < or = 4.88 at 24 hours of NIV treatment
Primary measure value of ROX index for prediction of failure of NIV in ARF patients. ROX index is the ratio of oxygen saturation as measured by pulse oximetry (SpO2)/ fraction of inspired oxygen (FIO2) to respiratory rate (RR). It will be analyzed as continuous value and dichotomized as < or = 4.88 at 48 hours of NIV treatment
Primary diaphragmatic thickness assessment by ultrasound ultrasonographic measurement of diaphragmatic thickness fraction for prediction of failure of NIV in ARF patients. at first 1 day of starting NIV treatment
Primary diaphragmatic dysfunction assessment by ultrasound ultrasonographic measurement of diaphragmatic excursion for prediction of failure of NIV in ARF patients. at first 1 day of starting NIV treatment
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05756387 - Improving Chronic Nocturnal Noninvasive Ventilation: a Multimodality Approach
Not yet recruiting NCT06259565 - Non-invasive Ventilation and Dexmedetomidine in Critically Ill Adults Phase 3
Completed NCT02973373 - MRI of the Chest Under High Frequency Ventilation N/A
Recruiting NCT06072339 - Optimization of Positive End Expiratory Pressure by Use of Pulmonary Ultrasound for Patients With Blunt Chest Trauma Treated by Non-Invasive Ventilation (Opti-PEP). N/A
Recruiting NCT04054622 - Patient-ventilator Asychrony During Non-invasive Ventilation When COPD Patients Doing Exercise
Completed NCT03859947 - High-flow Nasal Cannula Flow Rates, Severe Bronchiolitis
Completed NCT03149835 - NIV Reduces CBF in COPD Patients Without Cognitive Function N/A
Recruiting NCT04036175 - Comparison of Patient Work of Breathing and Tidal Volumes With High Flow Nasal Cannula Oxygen Therapy and NIV (Non-Invasive Ventilation) After Extubation in the ICU. N/A
Recruiting NCT02712190 - Evaluation of Prolonged Apnea Supported by High Frequency Non-invasive Ventilation. N/A
Not yet recruiting NCT05435183 - Effect of Noninvasive High Frequency Oscillatory Ventilation on Improving Carbon Dioxide Clearance in AECOPD Patients N/A
Recruiting NCT05796297 - Clinical Impact of Patient-ventilator Asynchrony
Not yet recruiting NCT05448417 - Exploration of Non-invasive High-frequency Oscillations in Human-machine Asynchrony in Healthy Subjects N/A
Completed NCT05031650 - Open Lung Strategy During Non-Invasive Respiratory Support of Very Preterm Infants in the Delivery Room N/A
Completed NCT03130361 - Wearable Noninvasive Positive Pressure Ventilation Device in COPD N/A
Completed NCT04178694 - The Influence of Non-invasive Ventilation on Metabolism in Healthy Volunteers N/A
Not yet recruiting NCT05721833 - Effect of Noninvasive High Frequency Oscillatory Ventilation on Improving CO2 Clearance in COPD Patients N/A
Not yet recruiting NCT05706467 - The Difference Between Non-invasive High-frequency Oscillatory Ventilation and Non-invasive Continuous Airway Pressure Ventilation in COVID-19 With Acute Hypoxemia N/A
Recruiting NCT01961245 - Effects of Nocturnal Non-invasive Ventilation on Energy Expenditure in Patients With Severe Chronic Obstructive Pulmonary Disease N/A
Recruiting NCT03978221 - Tissue Doppler Ultrasound During Spontaneous Breathing and Non-invasive Ventilation in the Post-extubation Period. N/A
Completed NCT04884828 - Asynchronies in NIV With External Gas